Literature DB >> 18841018

Cortical serotonin 1A receptor levels are associated with depression in patients with dementia with Lewy bodies and Parkinson's disease dementia.

Sally I Sharp1, Clive G Ballard, Iryna Ziabreva, Margaret A Piggott, Robert H Perry, Elaine K Perry, Dag Aarsland, Uwe Ehrt, Jan P Larsen, Paul T Francis.   

Abstract

BACKGROUND: Serotonin 1A receptors (5-HT(1A)) have not been studied in dementia with Lewy bodies (DLB) or Parkinson's disease dementia (PDD) patients with depression. AIM: To examine 5-HT(1A) in DLB and PDD postmortem in relation to depression.
METHODS: [(3)H]8-hydroxy-2-dipropylaminotetralin binding to 5-HT(1A) was determined in temporal cortex (Brodmann areas, BA20 and BA36) from 10 DLB patients, 17 PDD patients and 9 controls.
RESULTS: 5-HT(1A) density was significantly higher in BA36 in combined DLB/PDD patients with depression, but was unaltered in BA20.
CONCLUSION: Higher BA36 5-HT(1A) density in PDD and DLB patients than in control is dependent on whether the patient had experienced depression during life, not DLB/PDD diagnosis. A 5-HT(1A) antagonist adjuvant may improve treatment of depression in dementia. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18841018     DOI: 10.1159/000161058

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  12 in total

1.  Differential involvement of hippocampal serotonin1A receptors and re-uptake sites in non-cognitive behaviors of Alzheimer's disease.

Authors:  Mitchell K P Lai; Shirley W Tsang; Margaret M Esiri; Paul T Francis; Peter T-H Wong; Christopher P Chen
Journal:  Psychopharmacology (Berl)       Date:  2010-07-13       Impact factor: 4.530

2.  Clinical trials of dementia with Lewy bodies and Parkinson's disease dementia.

Authors:  D Aarsland; C Ballard; A Rongve; M Broadstock; P Svenningsson
Journal:  Curr Neurol Neurosci Rep       Date:  2012-10       Impact factor: 5.081

Review 3.  Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2017-12-08       Impact factor: 3.575

Review 4.  Depression in Parkinson disease--epidemiology, mechanisms and management.

Authors:  Dag Aarsland; Sven Påhlhagen; Clive G Ballard; Uwe Ehrt; Per Svenningsson
Journal:  Nat Rev Neurol       Date:  2011-12-26       Impact factor: 42.937

Review 5.  Biochemical and pathological correlates of cognitive and behavioural change in DLB/PDD.

Authors:  Paul T Francis
Journal:  J Neurol       Date:  2009-08       Impact factor: 4.849

Review 6.  Neuropsychiatric symptoms in patients with dementias associated with cortical Lewy bodies: pathophysiology, clinical features, and pharmacological management.

Authors:  Clive Ballard; Dag Aarsland; Paul Francis; Anne Corbett
Journal:  Drugs Aging       Date:  2013-08       Impact factor: 3.923

Review 7.  The serotonergic system in motor and non-motor manifestations of Parkinson's disease.

Authors:  Philippe Huot; Susan H Fox
Journal:  Exp Brain Res       Date:  2013-06-28       Impact factor: 1.972

8.  Factors associated with a depressive disorder in Alzheimer's disease are different from those found for other dementia disorders.

Authors:  Maria Lage Barca; Knut Engedal; Jerson Laks; Geir Selbaek
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2012-02-03

9.  Comprehensive treatment of dementia with Lewy bodies.

Authors:  Brendon P Boot
Journal:  Alzheimers Res Ther       Date:  2015-05-29       Impact factor: 6.982

10.  The monoaminergic footprint of depression and psychosis in dementia with Lewy bodies compared to Alzheimer's disease.

Authors:  Yannick Vermeiren; Debby Van Dam; Tony Aerts; Sebastiaan Engelborghs; Jean-Jacques Martin; Peter P De Deyn
Journal:  Alzheimers Res Ther       Date:  2015-02-11       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.